{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:24:47Z","timestamp":1793366687706,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103453"],"award-info":[{"award-number":["P20GM103453"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiogenesis is required for tissue repair; but abnormal angiogenesis or neovascularization (NV) causes diseases in the eye. The avascular status in the cornea is a prerequisite for corneal clarity and thought to be maintained by the equilibrium between proangiogenic and antiangiogenic factors that controls proliferation and migration of vascular endothelial cells (ECs) sprouting from the pericorneal plexus. VEGF is the most important intrinsic factor for angiogenesis; anti-VEGF therapies are available for treating ocular NV. However, the effectiveness of the therapies is limited because of VEGF-independent mechanism(s). We show that Zeb1 is an important factor promoting vascular EC proliferation and corneal NV; and a couple of small molecule inhibitors can evict Ctbp from the Zeb1\u2013Ctbp complex, thereby reducing EC Zeb1 expression, proliferation, and corneal NV. We conclude that Zeb1-regulation of angiogenesis is independent of Vegf and that\u00a0the ZEB1\u2013CtBP inhibitors can be of potential therapeutic significance in treating corneal NV.<\/jats:p>","DOI":"10.1038\/s42003-020-1069-z","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T10:02:57Z","timestamp":1593770577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Zeb1 promotes corneal neovascularization by regulation of vascular endothelial cell proliferation"],"prefix":"10.1038","volume":"3","author":[{"given":"Lei","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Piri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-0865","authenticated-orcid":false,"given":"Yongqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtbi.2018.09.020","volume":"459","author":"A Guerra","year":"2018","unstructured":"Guerra, A., Belinha, J. & Jorge, R. N. Modelling skin wound healing angiogenesis: a review. J. Theor. Biol. 459, 1\u201317 (2018).","journal-title":"J. Theor. Biol."},{"key":"1069_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2017.10.001","volume":"191","author":"Y Ma","year":"2018","unstructured":"Ma, Y., Mouton, A. J. & Lindsey, M. L. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl. Res. 191, 15\u201328 (2018).","journal-title":"Transl. Res."},{"key":"1069_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"JH Chang","year":"2012","unstructured":"Chang, J. H. et al. Corneal neovascularization: an anti-VEGF therapy review. Surv. Ophthalmol. 57, 415\u2013429 (2012).","journal-title":"Surv. Ophthalmol."},{"key":"1069_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-017-0084-9","volume":"3","author":"T Cabral","year":"2017","unstructured":"Cabral, T. et al. Retinal and choroidal angiogenesis: a review of new targets. Int J. Retin. Vitreous 3, 31 (2017).","journal-title":"Int J. Retin. Vitreous"},{"key":"1069_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/08820530902800017","volume":"24","author":"SR Montezuma","year":"2009","unstructured":"Montezuma, S. R., Vavvas, D. & Miller, J. W. Review of the ocular angiogenesis animal models. Semin. Ophthalmol. 24, 52\u201361 (2009).","journal-title":"Semin. Ophthalmol."},{"key":"1069_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0008-6363(00)00281-9","volume":"49","author":"EM Conway","year":"2001","unstructured":"Conway, E. M., Collen, D. & Carmeliet, P. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507\u2013521 (2001).","journal-title":"Cardiovasc. Res."},{"key":"1069_CR7","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2174\/09298673113206660264","volume":"21","author":"X Liang","year":"2014","unstructured":"Liang, X. et al. VEGF signal system: the application of antiangiogenesis. Curr. Med. Chem. 21, 894\u2013910 (2014).","journal-title":"Curr. Med. Chem."},{"key":"1069_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","volume":"49","author":"AV Ljubimov","year":"2015","unstructured":"Ljubimov, A. V. & Saghizadeh, M. Progress in corneal wound healing. Prog. Retin. Eye Res. 49, 17\u201345 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"1069_CR9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/156652409789712783","volume":"9","author":"MJ Tolentino","year":"2009","unstructured":"Tolentino, M. J. Current molecular understanding and future treatment strategies for pathologic ocular neovascularization. Curr. Mol. Med. 9, 973\u2013981 (2009).","journal-title":"Curr. Mol. Med."},{"key":"1069_CR10","first-page":"S3","volume":"24","author":"CC Wykoff","year":"2018","unstructured":"Wykoff, C. C. et al. Optimizing anti-VEGF treatment outcomes for patients with neovascular age-related macular degeneration. J. Manag. Care Spec. Pharm. 24, S3\u2013S15 (2018).","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"1069_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","volume":"16","author":"D Roshandel","year":"2018","unstructured":"Roshandel, D. et al. Current and emerging therapies for corneal neovascularization. Ocul. Surf. 16, 398\u2013414 (2018).","journal-title":"Ocul. Surf."},{"key":"1069_CR12","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","volume":"69","author":"E Sanchez-Tillo","year":"2012","unstructured":"Sanchez-Tillo, E. et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol. Life Sci. 69, 3429\u20133456 (2012).","journal-title":"Cell Mol. Life Sci."},{"key":"1069_CR13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1101\/gad.1640608","volume":"22","author":"SM Park","year":"2008","unstructured":"Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894\u2013907 (2008).","journal-title":"Genes Dev."},{"key":"1069_CR14","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1158\/0008-5472.CAN-05-2881","volume":"66","author":"NS Spoelstra","year":"2006","unstructured":"Spoelstra, N. S. et al. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res. 66, 3893\u20133902 (2006).","journal-title":"Cancer Res."},{"key":"1069_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/embor.2010.117","volume":"11","author":"S Brabletz","year":"2010","unstructured":"Brabletz, S. & Brabletz, T. The ZEB\/miR-200 feedback loop\u2013a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670\u2013677 (2010).","journal-title":"EMBO Rep."},{"key":"1069_CR16","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1172\/JCI63608","volume":"122","author":"YH Ahn","year":"2012","unstructured":"Ahn, Y. H. et al. ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J. Clin. Investig. 122, 3170\u20133183 (2012).","journal-title":"J. Clin. Investig."},{"key":"1069_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel, J. et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24, 466\u2013480 (2013).","journal-title":"Cancer Cell"},{"key":"1069_CR18","doi-asserted-by":"publisher","first-page":"11572","DOI":"10.1074\/jbc.M112.434951","volume":"288","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression. J. Biol. Chem. 288, 11572\u201311580 (2013).","journal-title":"J. Biol. Chem."},{"key":"1069_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3650","volume":"4","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Rb1 family mutation is sufficient for sarcoma initiation. Nat. Commun. 4, 2650 (2013).","journal-title":"Nat. Commun."},{"key":"1069_CR20","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1172\/JCI72171","volume":"124","author":"YA Yang","year":"2014","unstructured":"Yang, Y. A. et al. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J. Clin. Investig. 124, 2696\u20132708 (2014).","journal-title":"J. Clin. Investig."},{"key":"1069_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.395","volume":"5","author":"JV Joseph","year":"2014","unstructured":"Joseph, J. V. et al. TGF-beta is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis. 5, e1443 (2014).","journal-title":"Cell Death Dis."},{"key":"1069_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6660","volume":"5","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. Nat. Commun. 5, 5660 (2014).","journal-title":"Nat. Commun."},{"key":"1069_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ncb3013","volume":"16","author":"P Zhang","year":"2014","unstructured":"Zhang, P. et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. Cell Biol. 16, 864\u2013875 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1069_CR24","doi-asserted-by":"publisher","first-page":"36101","DOI":"10.1074\/jbc.M114.598383","volume":"289","author":"Y Tian","year":"2014","unstructured":"Tian, Y. et al. MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells. J. Biol. Chem. 289, 36101\u201336115 (2014).","journal-title":"J. Biol. Chem."},{"key":"1069_CR25","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1172\/JCI76725","volume":"126","author":"JE Larsen","year":"2016","unstructured":"Larsen, J. E. et al. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J. Clin. Invest. 126, 3219\u20133235 (2016).","journal-title":"J. Clin. Invest."},{"key":"1069_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00079-x","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. ZEB1 regulates multiple oncogenic components involved in uveal melanoma progression. Sci. Rep. 7, 45 (2017).","journal-title":"Sci. Rep."},{"key":"1069_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04663-1","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Mitotic polarization of transcription factors during asymmetric division establishes fate of forming cancer cells. Nat. Commun. 9, 2424 (2018).","journal-title":"Nat. Commun."},{"key":"1069_CR28","doi-asserted-by":"publisher","first-page":"e0148774","DOI":"10.1371\/journal.pone.0148774","volume":"11","author":"L Liu","year":"2016","unstructured":"Liu, L. et al. ZEB1 Upregulates VEGF expression and stimulates angiogenesis in breast cancer. PLoS ONE 11, e0148774 (2016).","journal-title":"PLoS ONE"},{"key":"1069_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15384047.2017.1323586","volume":"18","author":"MM Dcona","year":"2017","unstructured":"Dcona, M. M., Morris, B. L., Ellis, K. C. & Grossman, S. R. CtBP-an emerging oncogene and novel small molecule drug target: advances in the understanding of its oncogenic action and identification of therapeutic inhibitors. Cancer Biol. Ther. 18, 379\u2013391 (2017).","journal-title":"Cancer Biol. Ther."},{"key":"1069_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.molcel.2015.01.023","volume":"58","author":"K Ichikawa","year":"2015","unstructured":"Ichikawa, K. et al. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP. Mol. Cell 58, 35\u201346 (2015).","journal-title":"Mol. Cell"},{"key":"1069_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ab.2005.02.012","volume":"340","author":"V Rishi","year":"2005","unstructured":"Rishi, V. et al. A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. Anal. Biochem. 340, 259\u2013271 (2005).","journal-title":"Anal. Biochem."},{"key":"1069_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1242\/dev.125.1.21","volume":"125","author":"T Takagi","year":"1998","unstructured":"Takagi, T., Moribe, H., Kondoh, H. & Higashi, Y. DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development 125, 21\u201331 (1998).","journal-title":"Development"},{"key":"1069_CR33","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.185.8.1467","volume":"185","author":"Y Higashi","year":"1997","unstructured":"Higashi, Y. et al. Impairment of T cell development in deltaEF1 mutant mice. J. Exp. Med. 185, 1467\u20131479 (1997).","journal-title":"J. Exp. Med."},{"key":"1069_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.survophthal.2017.12.008","volume":"63","author":"W Zhong","year":"2018","unstructured":"Zhong, W. et al. Angiogenesis and lymphangiogenesis in corneal transplantation-A review. Surv. Ophthalmol. 63, 453\u2013479 (2018).","journal-title":"Surv. Ophthalmol."},{"key":"1069_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.12968\/jowc.2009.18.12.45609","volume":"18","author":"M Przybylski","year":"2009","unstructured":"Przybylski, M. A review of the current research on the role of bFGF and VEGF in angiogenesis. J. Wound Care 18, 516\u2013519 (2009).","journal-title":"J. Wound Care"},{"key":"1069_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson, A. K., Dimberg, A., Kreuger, J. & Claesson-Welsh, L. VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Bio. 7, 359\u2013371 (2006).","journal-title":"Nat. Rev. Mol. Cell Bio."},{"issue":"Suppl A","key":"1069_CR37","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/plac.1999.0525","volume":"21","author":"G Breier","year":"2000","unstructured":"Breier, G. Angiogenesis in embryonic development\u2013a review. Placenta 21(Suppl A), S11\u201315 (2000).","journal-title":"Placenta"},{"key":"1069_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12867-015-0038-4","volume":"16","author":"KC Dean","year":"2015","unstructured":"Dean, K. C., Huang, L., Chen, Y., Lu, X. & Liu, Y. An Rb1-dependent amplification loop between Ets1 and Zeb1 is evident in thymocyte differentiation and invasive lung adenocarcinoma. BMC Mol. Biol. 16, 8 (2015).","journal-title":"BMC Mol. Biol."},{"key":"1069_CR39","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1074\/jbc.M113.533505","volume":"289","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression. J. Biol. Chem. 289, 4116\u20134125 (2014).","journal-title":"J. Biol. Chem."},{"key":"1069_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1242\/dev.007047","volume":"135","author":"Y Liu","year":"2008","unstructured":"Liu, Y., El-Naggar, S., Darling, D. S., Higashi, Y. & Dean, D. C. Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135, 579\u2013588 (2008).","journal-title":"Development"},{"key":"1069_CR41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/cbin.10223","volume":"38","author":"J Dou","year":"2014","unstructured":"Dou, J. et al. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs. Cell Biol. Int. 38, 452\u2013461 (2014).","journal-title":"Cell Biol. Int."},{"key":"1069_CR42","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.4161\/cc.9.18.12936","volume":"9","author":"MW Straza","year":"2010","unstructured":"Straza, M. W. et al. Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle 9, 3740\u20133750 (2010).","journal-title":"Cell Cycle"},{"key":"1069_CR43","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1146\/annurev.biochem.71.110601.135507","volume":"71","author":"IA Olave","year":"2002","unstructured":"Olave, I. A., Reck-Peterson, S. L. & Crabtree, G. R. Nuclear actin and actin-related proteins in chromatin remodeling. Annu. Rev. Biochem. 71, 755\u2013781 (2002).","journal-title":"Annu. Rev. Biochem."},{"key":"1069_CR44","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.1128\/MCB.19.12.8581","volume":"19","author":"T Furusawa","year":"1999","unstructured":"Furusawa, T., Moribe, H., Kondoh, H. & Higashi, Y. Identification of CtBP1 and CtBP2 as corepressors of zinc finger-homeodomain factor deltaEF1. Mol. Cell Biol. 19, 8581\u20138590 (1999).","journal-title":"Mol. Cell Biol."},{"key":"1069_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bcmd.2007.04.001","volume":"39","author":"ZK Otrock","year":"2007","unstructured":"Otrock, Z. K., Mahfouz, R. A., Makarem, J. A. & Shamseddine, A. I. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol. Dis. 39, 212\u2013220 (2007).","journal-title":"Blood Cells Mol. Dis."},{"key":"1069_CR46","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1136\/bjophthalmol-2017-311055","volume":"102","author":"M Kataja","year":"2018","unstructured":"Kataja, M. et al. Outcome of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in real-life setting. Br. J. Ophthalmol. 102, 959\u2013965 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"1069_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.sjopt.2017.02.008","volume":"31","author":"T Al-Debasi","year":"2017","unstructured":"Al-Debasi, T., Al-Bekairy, A., Al-Katheri, A., Al Harbi, S. & Mansour, M. Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. Saudi J. Ophthalmol. 31, 99\u2013105 (2017).","journal-title":"Saudi J. Ophthalmol."},{"key":"1069_CR48","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1167\/iovs.05-0548","volume":"46","author":"M Ueno","year":"2005","unstructured":"Ueno, M. et al. Accelerated wound healing of alkali-burned corneas in MRL mice is associated with a reduced inflammatory signature. Invest. Ophthalmol. Vis. Sci. 46, 4097\u20134106 (2005).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1069_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/bjo.78.5.401","volume":"78","author":"HS Dua","year":"1994","unstructured":"Dua, H. S., Gomes, J. A. & Singh, A. Corneal epithelial wound healing. Br. J. Ophthalmol. 78, 401\u2013408 (1994).","journal-title":"Br. J. Ophthalmol."},{"key":"1069_CR50","doi-asserted-by":"publisher","first-page":"e0179982","DOI":"10.1371\/journal.pone.0179982","volume":"12","author":"JW Kim","year":"2017","unstructured":"Kim, J. W., Lim, C. W. & Kim, B. Effects of nicotine on corneal wound healing following acute alkali burn. PLoS ONE 12, e0179982 (2017).","journal-title":"PLoS ONE"},{"key":"1069_CR51","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1091\/mbc.e07-03-0249","volume":"18","author":"T Shirakihara","year":"2007","unstructured":"Shirakihara, T., Saitoh, M. & Miyazono, K. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol. Biol. Cell 18, 3533\u20133544 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"1069_CR52","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1167\/iovs.06-1083","volume":"48","author":"S Fujita","year":"2007","unstructured":"Fujita, S. et al. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice. Invest. Ophthalmol. Vis. Sci. 48, 3051\u20133055 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1069_CR53","doi-asserted-by":"crossref","unstructured":"Anderson, C., Zhou, Q. & Wang, S. An alkali-burn injury model of corneal neovascularization in the mouse. J. Vis. Exp. 86, 51159 (2014).","DOI":"10.3791\/51159"},{"key":"1069_CR54","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2144\/000112010","volume":"39","author":"R Shi","year":"2005","unstructured":"Shi, R. & Chiang, V. L. Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 39, 519\u2013525 (2005).","journal-title":"Biotechniques"},{"key":"1069_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1069_CR56","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1167\/iovs.08-2911","volume":"50","author":"Y Liu","year":"2009","unstructured":"Liu, Y. et al. Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology. Invest. Ophthalmol. Vis. Sci. 50, 5080\u20135088 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1069-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T02:24:31Z","timestamp":1670379871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1069-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1038\/s42003-020-1069-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"6 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"349"}}